Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy Journal Article


Authors: Bercz, A.; Park, B. K.; Pappou, E.; Nemirovsky, D.; Sarkar, R.; Yamner, M.; Omer, D.; Verheij, F. S.; Alvarez, J.; Atri, P.; Reyngold, M.; Yaeger, R.; Wei, I. H.; Wu, A.; Raj, N.; Widmar, M.; Hajj, C.; Kim, M. J.; Rao, D.; Nash, G. M.; Williams, V.; Shia, J.; Segal, N. H.; Diaz, L.; Ganesh, K.; Weiser, M. R.; Gollub, M. J.; Paty, P. B.; Horvat, N.; Zinovoy, M.; Roth O'Brien, D.; Sanchez-Vega, F.; Saltz, L. B.; Crane, C. H.; Cercek, A.; Gonen, M.; Garcia-Aguilar, J.; Smith, J. J.; Romesser, P. B.
Article Title: Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy
Abstract: Background: Potential differences in organ preservation between total neoadjuvant therapy (TNT) regimens integrating long-course chemoradiotherapy (LCCRT) and short-course radiotherapy (SCRT) in rectal cancer remain undefined. Patients and methods: This natural experiment arose from a policy change in response to the COVID-19 pandemic during which our institution switched from uniformly treating patients with LCCRT to mandating that all patients be treated with SCRT. Our study includes 323 locally advanced rectal adenocarcinoma patients treated with LCCRT-based or SCRT-based TNT from January 2018 to January 2021. Patients who achieved clinical complete response were offered organ preservation with watch-and-wait (WW) management. The primary outcome was 2-year organ preservation. Additional outcomes included local regrowth, distant recurrence, disease-free survival (DFS), and overall survival (OS). Results: Patient and tumor characteristics were similar between LCCRT (n = 247) and SCRT (n = 76) cohorts. Median follow-up was 31 months. Similar clinical complete response rates were observed following LCCRT and SCRT (44.5% versus 43.4%). Two-year organ preservation was 40% [95% confidence interval (CI) 34% to 46%] and 31% (95% CI 22% to 44%) among all patients treated with LCCRT and SCRT, respectively. In patients managed with WW, LCCRT resulted in higher 2-year organ preservation (89% LCCRT, 95% CI 83% to 95% versus 70% SCRT, 95% CI 55% to 90%; P = 0.005) and lower 2-year local regrowth (19% LCCRT, 95% CI 11% to 26% versus 36% SCRT, 95% CI 16% to 52%; P = 0.072) compared with SCRT. The 2-year distant recurrence (10% versus 6%), DFS (90% versus 90%), and OS (99% versus 100%) were similar between WW patients treated with LCCRT and SCRT, respectively. Conclusions: While WW eligibility was similar between cohorts, WW patients treated with LCCRT had higher 2-year organ preservation and lower local regrowth than those treated with SCRT, yet similar DFS and OS. These data support induction LCCRT followed by consolidation chemotherapy as the preferred TNT regimen for patients with locally advanced rectal cancer pursuing organ preservation. © 2024 European Society for Medical Oncology
Keywords: organ preservation; rectal cancer; short-course radiotherapy; local regrowth; long-course chemoradiotherapy; natural experiment
Journal Title: Annals of Oncology
Volume: 35
Issue: 11
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2024-11-01
Start Page: 1003
End Page: 1014
Language: English
DOI: 10.1016/j.annonc.2024.07.729
PUBMED: 39266364
PROVIDER: scopus
PMCID: PMC11513239
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Corresponding authors is MSK author: Paul B. Romesser -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Melissa Remis Zinovoy
    51 Zinovoy
  2. Leonard B Saltz
    792 Saltz
  3. Philip B Paty
    501 Paty
  4. Marc J Gollub
    209 Gollub
  5. Neil Howard Segal
    211 Segal
  6. Mithat Gonen
    1033 Gonen
  7. Jinru Shia
    721 Shia
  8. Martin R Weiser
    541 Weiser
  9. Bernard J Park
    268 Park
  10. Rona Denit Yaeger
    324 Yaeger
  11. Marsha Reyngold
    105 Reyngold
  12. Abraham Jing-Ching Wu
    405 Wu
  13. Garrett Nash
    267 Nash
  14. Carla Hajj
    166 Hajj
  15. Paul Bernard Romesser
    195 Romesser
  16. Nitya Prabhakar Raj
    109 Raj
  17. Jesse Joshua Smith
    227 Smith
  18. Karuna   Ganesh
    70 Ganesh
  19. Maria   Widmar
    78 Widmar
  20. Christopher   Crane
    206 Crane
  21. Natally Horvat
    105 Horvat
  22. Luis Alberto Diaz
    153 Diaz
  23. Emmanouil Pappou
    93 Pappou
  24. Iris Hsin - chu Wei
    68 Wei
  25. Floris Stefanus Verheij
    37 Verheij
  26. Devika Rao
    7 Rao
  27. Reith Roy Sarkar
    26 Sarkar
  28. Dana Mohamed Rashid Omer
    34 Omer
  29. Aron Peter Bercz
    12 Bercz
  30. Min Jung Kim
    3 Kim
  31. Pranita Atri
    3 Atri
  32. Miles Elliot Yamner
    1 Yamner